Business Description
Nanogroup SA
ISIN : PLNNGRP00011
Compare
Compare
Traded in other countries / regions
NNG.Poland IPO Date
2017-12-21Description
Nanogroup SA develops biotechnological and medical projects for diagnostics, therapy and rehabilitation of oncological patients. The company's portfolio includes Nano Velos, Nano Sanguis, and Nano Thea.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 15.41 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 0.59 | |||||
Beneish M-Score | -1.6 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -31.6 | |||||
3-Year EBITDA Growth Rate | 22.1 | |||||
3-Year EPS without NRI Growth Rate | 25.9 | |||||
3-Year FCF Growth Rate | 5.1 | |||||
3-Year Book Growth Rate | -21.6 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.98 | |||||
9-Day RSI | 50.35 | |||||
14-Day RSI | 55.4 | |||||
6-1 Month Momentum % | 316.14 | |||||
12-1 Month Momentum % | 278.1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.46 | |||||
Quick Ratio | 0.45 | |||||
Cash Ratio | 0.35 | |||||
Days Inventory | 129.4 | |||||
Days Payable | 310.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -4.25 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 2133.33 | |||||
Operating Margin % | 24611.11 | |||||
Net Margin % | 24066.67 | |||||
FCF Margin % | 35305.56 | |||||
ROE % | -63.97 | |||||
ROA % | -24.54 | |||||
ROIC % | -26.82 | |||||
ROC (Joel Greenblatt) % | -833.88 | |||||
ROCE % | -28.42 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 21.71 | |||||
EV-to-EBIT | -18.19 | |||||
EV-to-EBITDA | -18.3 | |||||
EV-to-Revenue | -4477.5 | |||||
EV-to-FCF | -12.68 | |||||
Earnings Yield (Greenblatt) % | -5.5 | |||||
FCF Yield % | -7.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanogroup SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | -0.018 | ||
EPS (TTM) (zł) | -0.274 | ||
Beta | 0.89 | ||
Volatility % | 127.44 | ||
14-Day RSI | 55.4 | ||
14-Day ATR (zł) | 0.313264 | ||
20-Day SMA (zł) | 3.576 | ||
12-1 Month Momentum % | 278.1 | ||
52-Week Range (zł) | 0.85 - 4.37 | ||
Shares Outstanding (Mil) | 23.27 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nanogroup SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nanogroup SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Nanogroup SA Frequently Asked Questions
What is Nanogroup SA(WAR:NNG)'s stock price today?
The current price of WAR:NNG is zł3.51. The 52 week high of WAR:NNG is zł4.37 and 52 week low is zł0.85.
When is next earnings date of Nanogroup SA(WAR:NNG)?
The next earnings date of Nanogroup SA(WAR:NNG) is .
Does Nanogroup SA(WAR:NNG) pay dividends? If so, how much?
Nanogroup SA(WAR:NNG) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |